← brief for 2026-08-10 · Slowing decline
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Key takeaways
This trial is starting. It tests a pill called empagliflozin against a placebo (a dummy pill) in children ages 2 to 17 with kidney disease. This drug already helps adults with kidney disease. The study will see if it is safe and helps children, and there are no results yet.
Who did this work
Boehringer Ingelheim